Registry for tracking results of heart ablation procedures

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The TRAC-AF Registry aims to gather real-world data on the safety and effectiveness of AtriCure devices used in cardiac ablation procedures. It focuses on patients who are undergoing or have undergone open heart or hybrid ablation, including management of the Left Atrial Appendage. The collected data will inform product development, regulatory submissions, and scientific publications, ensuring that AtriCure remains updated on the performance of their devices in clinical settings.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Patient has been scheduled by physician(s) to undergo or has undergone cardiac ablation procedure(s)
2. Patient is willing to provide informed consent
3. Patient whose age is 18 years or above, or of legal age to give informed consent specific to state and national law

Exclusion Criteria:

1\. Other medical, social, or psychological conditions that in the opinion of the Investigator precludes the subject from appropriate consent or adherence to the protocol.

Where it's running

• Huntsville Hospital
  Huntsville, Alabama, United States Recruiting
• St. Bernards Medical Center
  Jonesboro, Arkansas, United States Recruiting
• CHI St. Vincent Heart Institute
  Little Rock, Arkansas, United States Recruiting
• Loma Linda University Medical Center
  Loma Linda, California, United States Recruiting
• Adventist Heart Institute (St. Helena Hospital)
  St. Helena, California, United States Recruiting
• Valley View Hospital
  Glenwood Springs, Colorado, United States Recruiting

Study contacts

• Study coordinator: Jarrod Goodarz, BA
• Email: jgoodarz@atricure.com
• Phone: 609-331-6621

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals

  This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.

  Recruiting at 2 sites Hospital Universitari Vall d'Hebron Research Institute · Leuven and 6 other locations · NCT07924371

• Left-atrial Fibrosis in Persistent Atrial Fibrillation and Its Comorbidities

  This study tests how comorbid conditions like sleep apnea and primary aldosteronism relate to left-atrial fibrosis and AF recurrence in patients undergoing ablation.

  Recruiting University Hospital Augsburg · Augsburg, Bavaria · NCT07857044

• Dual Energy ablation with SmartTouch SF catheter in persistent atrial fibrillation

  This study tests a pulsed field and radiofrequency ablation system to treat persistent atrial fibrillation in adults who have not responded well to prior medications.

  Recruiting at 4 sites Biosense Webster, Inc. · Beijing and 3 other locations · NCT07845682

• Identifying AF patients who may need more than standard ablation using Volta AF-Xplorer II

  This trial tests whether AI-identified dispersion areas during AF ablation can predict recurrence after a standard pulmonary vein isolation in patients with persistent AF.

  Recruiting Volta Medical · Avignon and 4 other locations · NCT07807423

• 4D intracardiac echocardiography to guide left atrial appendage occlusion procedures

  A new 4D ICE catheter is being tested alongside standard imaging to see if it can safely guide left atrial appendage occlusion procedures for adults with atrial fibrillation.

  Recruiting The Cleveland Clinic · Cleveland, Ohio · NCT07806890

• Thoracoscopic vs Catheter Ablation as the First Rhythm Control in Atrial Fibrillation with a Large Left Atrium

  This trial tests whether thoracoscopic surgical ablation is better at keeping atrial fibrillation under control than catheter ablation in people with persistent AF and a large left atrium who have not had an ablation before.

  Recruiting Samsung Medical Center · Seoul, Seoul · NCT07783984

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.